Bessemer Group
PGNX

Bessemer Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bessemer Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-344
Closed -$2K – 1528
2016
Q1 		$2K Buy
+344
New +$2K ﹤0.01% 1409